PROVIDER PROFILE · NPI 1285895003

Nisha DesaiM.D.

DermatologySkokie, ILI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

2,104

Unique beneficiaries

—

Total services

3,178

Distinct HCPCS

Medicare payment

$97K

Peer benchmark

Total Medicare services vs. 480 Dermatology providers in IL — above median (cohort median 2,329).

PRESCRIBING · PART D · 2024

Total Rx claims

905

Beneficiaries

—

Total drug cost

$22K

Distinct drugs

Brand share

2.3%

Top prescribed drugs

Ketoconazole192 claims

Clobetasol Propionate147 claims

Triamcinolone Acetonide135 claims

Clindamycin Phosphate64 claims

Mometasone Furoate55 claims

QUALITY · MIPS · 2024

Final MIPS score

84.9

Quality

75.9

Cost

74.6

Improvement activities

40.0

Promoting interop.

99.0

Payment adjustment

0.42%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$187

Payment records

By payment type

Food and Beverage$187

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 140010

Hospital

REFERRAL NETWORK

Where Nisha Desai's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 4 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
ENDEAVOR HEALTH CLINICAL OPERATIONS	332	2,228
Thomas Cibull Pathology · Evanston, IL	129	332

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
ENDEAVOR HEALTH CLINICAL OPERATIONS	178	1,004
VICTOR, THOMAS	54	151
Thomas Cibull Pathology · Evanston, IL	15	31
ENDEAVOR HEALTH CLINICAL OPERATIONS	13	48

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history